GMP
IPO Guru

Accretion Nutraveda SME IPO GMP Today, Live Kostak and Subject to Sauda Price

IPO
GMP Price
-
--
Kostak Rate
Retail -
SHNI -
BHNI -
Subject to Sauda
Retail -
SHNI -
BHNI -

Accretion Nutraveda IPO Grey Market Premium (GMP) today stands at -, indicating cautious or neutral market sentiment ahead of listing. The Kostak rate is currently not available, while the Subject to Sauda price is quoted at currently not available. On 20 January 2026, the IPO GMP recorded a high of and a low of ₹0 on N/A, reflecting a quiet phase in the grey market. You can check the day-wise GMP trend below to track price movement and investor sentiment over time.

Accretion Nutraveda IPO is scheduled to open for subscription on January 27, 2026. The public issue aims to raise around 24.77 cr and is offered in a price band of 122-129 per share, with a market lot of 1000 shares. Investors are closely watching subscription data and grey market trends ahead of the listing.

Day-wise GMP Trend

Date GMP (₹) Trend GMP (%) Kostak Subject to Sauda
20 Jan, 2026 - -- - -

Accretion Nutraveda IPO Dates

Event Date
Open Date 27 Jan, 2026
Close Date 30 Jan, 2026
Allotment Date 02 Feb, 2026
Refund Date 03 Feb, 2026
Credit to Demat 03 Feb, 2026
Listing Date 04 Feb, 2026

About Accretion Nutraveda IPO

Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.

The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nut...

Frequently Asked Questions about Accretion Nutraveda IPO

What is the GMP of Accretion Nutraveda IPO?

The current Grey Market Premium (GMP) of Accretion Nutraveda IPO is not yet started or active in the market.

What is the Kostak Price of Accretion Nutraveda IPO?

Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Accretion Nutraveda IPO is : Retail: -, SHNI: -, BHNI: -.

What is the Subject to Sauda Price of Accretion Nutraveda IPO?

Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is : Retail: -, SHNI: -, BHNI: -.

Advertisement